SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055067
Filing Date
2021-11-08
Accepted
2021-11-08 08:06:28
Documents
78
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q3 2021 kdny-10q_20210930.htm   iXBRL 10-Q 3576232
2 EX-31.1 kdny-ex311_7.htm EX-31.1 21124
3 EX-31.2 kdny-ex312_8.htm EX-31.2 21417
4 EX-32.1 kdny-ex321_6.htm EX-32.1 8140
  Complete submission text file 0001564590-21-055067.txt   11748816

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA kdny-20210930.xsd EX-101.SCH 64367
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kdny-20210930_cal.xml EX-101.CAL 70199
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kdny-20210930_def.xml EX-101.DEF 183381
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20210930_lab.xml EX-101.LAB 481576
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20210930_pre.xml EX-101.PRE 378791
10 EXTRACTED XBRL INSTANCE DOCUMENT kdny-10q_20210930_htm.xml XML 2459057
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 211386594
SIC: 2834 Pharmaceutical Preparations